Winchester Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q3
$3.48M Sell
69,195
-1,750
-2% -$91.6K 0.77% 39
2013
Q2
$3.48M Buy
+70,945
New +$3.86M 0.74% 37

Other funds holding LLY

Winchester Group's LLY Position: Q3 2013 in Review

Winchester Group reduced its Eli Lilly (LLY) stake by 2.5% in Q3 2013, selling an estimated $91.6K and leaving 69,195 shares worth $3.48M. The position accounts for 0.77% of the portfolio, ranked #39.

Winchester Group first reported a position in LLY in Q2 2013 and has held it in 2 quarters since. The position peaked at $3.48M in Q2 2013. 974 funds tracked by Wall St. Rank hold LLY as of Q3 2013.

  • Winchester Group held 69,195 shares of Eli Lilly worth $3.48M as of Q3 2013.
  • Winchester Group sold 1,750 Eli Lilly shares in Q3 2013, an estimated $91.6K.
  • Eli Lilly made up 0.77% of Winchester Group's portfolio in Q3 2013, its #39 holding.
  • Winchester Group first reported a position in Eli Lilly in Q2 2013 and has held it in 2 quarters since.
  • Winchester Group's Eli Lilly position peaked at $3.48M in Q2 2013.
  • 974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2013.

Based on Winchester Group's 13F filing for Q3 2013, filed 16 Oct 2013.